Log In
person
Allergan Inc.
AGN.2
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2014
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Medical Devices |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
0.66B | 9.29% |
| Medical Devices |
Breast Implants
These companies manufacture breast implants.
|
0.41B | 5.71% |
| Medical Devices |
Biologically-Derived Tissue Scaffolding Products; private insurance
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell directly to their customers. These are used for skin wound healing and dermal reconstruction. Their products are paid for primarily through private health insurance.
|
0.05B | 0.64% |
| Specialty Pharmaceuticals |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
6.01B | 84.37% |
| keyboard_arrow_down |
Medical Devices
Branded Pharmaceuticals
|
0.66B | 9.29% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Medical Devices
Breast Implants
|
0.41B | 5.71% |
| keyboard_arrow_right |
These companies manufacture breast implants.
|
||
| keyboard_arrow_down |
Medical Devices
Biologically-Derived Tissue Scaffolding Products; private insurance
|
0.05B | 0.64% |
| keyboard_arrow_right |
These companies manufacture tissue scaffolding products, primarily from placental tissue (such as amniotic membrane allografts) and sell directly to their customers. These are used for skin wound healing and dermal reconstruction. Their products are paid for primarily through private health insurance.
|
||
| keyboard_arrow_down |
Specialty Pharmaceuticals
Branded Pharmaceuticals
|
6.01B | 84.37% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||